Human SARS-CoV-2 challenge uncovers local and systemic response dynamics

Rik G.H. Lindeboom(Wellcome Sanger Institute), Kaylee B. Worlock(University College London), Lisa M. Dratva(Wellcome/MRC Cambridge Stem Cell Institute), Masahiro Yoshida(University College London), Scobie Dr(University College London), Helen R. Wagstaffe(Imperial College London), Laura Richardson(Wellcome Sanger Institute), Anna Wilbrey-Clark(Wellcome Sanger Institute), Josephine L. Barnes(University College London), Lorenz Kretschmer(Wellcome Sanger Institute), Krzysztof Polański(Wellcome Sanger Institute), Jessica Allen-Hyttinen(University College London), Puja Mehta(University College London), Dinithi Sumanaweera(Wellcome Sanger Institute), Jacqueline Marcia Boccacino(Wellcome Sanger Institute), Waradon Sungnak(Mahidol University), Rasa Elmentaite(Wellcome Sanger Institute), Ni Huang(Wellcome Sanger Institute), Lira Mamanova(Wellcome Sanger Institute), Rakesh Kapuge(Wellcome Sanger Institute), Liam Bolt(Wellcome Sanger Institute), Elena Prigmore(Wellcome Sanger Institute), Ben Killingley(University College Hospital), Mariya Kalinova(hVIVO (United Kingdom)), Maria Goeppert Mayer(hVIVO (United Kingdom)), Alison Boyers(hVIVO (United Kingdom)), Alex Mann(hVIVO (United Kingdom)), Leo Swadling(University College London), Maximillian Woodall(Great Ormond Street Hospital), Samuel Ellis(Great Ormond Street Hospital), Claire M. Smith(Great Ormond Street Hospital), Vitor H. Teixeira(University College London), Sam M. Janes(University College London), Rachel C. Chambers(University College London), Muzlifah Haniffa(Wellcome Sanger Institute), Andrew Catchpole(hVIVO (United Kingdom)), Robert S. Heyderman(University College London), Mahdad Noursadeghi(University College London), Benny Chain(University College London), Andreas Mayer(University College London), Kerstin B. Meyer(Wellcome Sanger Institute), Christopher Chiu(Imperial College London), Marko Nikolić(UCL Biomedical Research Centre), Sarah A. Teichmann(Wellcome/MRC Cambridge Stem Cell Institute)
Nature
June 19, 2024
Cited by 121Open Access
Full Text

Abstract

. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection.


Related Papers

No related papers found

Powered by citation graph analysis